Top Report on Ophthalmology Therapeutics Market 2019

2013-11-07
Published : Nov-2013

The report “Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity″ by  GBI Research is now available at RnRMarketResearch.com. Contact [email protected] with Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity in subject line and your contact details to purchase this report or get your questions answered.

The collection of ‘Ophthalmology therapeutics’ market research reports has a new addition of “Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity on RnRMarketResearch.com “Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity”, which provides insights into two therapeutic indications in ophthalmology in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the therapeutic indications of ophthalmology, namely glaucoma and Dry Eye Syndrome (DES). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these two ophthalmology indications.

Request a sample copy of this report by GBI Research@ http://www.rnrmarketresearch.com/contacts/request-sample?rname=127327 .

Scope

  • Disease overview and treatment usage patterns
  • Market size and forecast for glaucoma and DES in APAC market from 2012 to 2019
  • Major marketed products for the indications types covered
  • In-depth pipeline analysis for glaucoma and DES
  • Key drivers and restraints that have had and are expected to have a significant impact upon the market
  • Key licensing and co-development agreements in the ophthalmology market

Complete report is available @ http://www.rnrmarketresearch.com/ophthalmology-therapeutics-market-in-asia-pacific-to-2019-high-unmet-need-and-moderate-short-term-prospects-focus-attention-on-early-stage-activity-market-report.html . Read more on Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity” report below.

Reasons to Buy

The report will enhance your decision-making capability by allowing you to:

  • Align your product portfolio to the markets with high growth potential
  • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
  • Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the ophthalmology market
  • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

 For further information on Ophthalmology Therapeutics Market in Asia-Pacific to 2019 – High Unmet Need and Moderate Short Term Prospects Focus Attention on Early Stage Activity” report OR for any other business research / market intelligence need on the ‘Ophthalmology therapeutics’ market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics .), contact [email protected] / Call +1 888 391 5441.

Filed in: Infusion Therapy Devices, Medical Device, Orthopedic Devices
More Reports
Title Price Buy Now

Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)], Technology (Traditional, Specialty), Application (Cancer, Diabetes), & Setting (Hospital, Homecare) – Global Forecast to 2026

The infusion pump market is expected to grow at a CAGR of 9.3% in the forecast period. The infusion pumps market is expected to reach USD 20.5 Billion by 2026 from an estimated USD 13.2 Billion in 2021, at a CAGR of 9.3%. The increasing incidence of chronic diseases along with the rapid growth of the geriatric population, rising demand for ambulatory infusion pumps, and the growing volume of surgical procedures performed across the globe are some of the key factors driving the growth of the infusion pumps market. However, the presence of stringent regulations for new products, medication errors associated with infusion pumps (which have resulted in product recalls), and the increasing adoption of refurbished and rental infusion pumps are expected to restrain the growth of this market du......
$4950

Asia-Pacific Infusion Therapy Devices Market 2012 Report

The Asia-Pacific infusion therapy device markets exceeded $534 million in 2011. This market includes: needleless connectors, infusion pumps and intravenous (IV) sets. Countries in this report include: Japan South Korea Australia Within the Asia-Pacific infusion therapy device market , companies such as  Terumo and Japan-based JMS were market leaders. This report provides a  comprehensive and detailed analysis of market revenues by device type, market  forecasts through 2018, unit sales, average selling prices, market drivers and  limiters and a detailed competitive analysis, including manufacturer market  shares and product portfolios. APAC Infusion Therapy Devices Market Published: March 2012 No. of Pages: 206 Price : Single User License - US$7995     ......
$
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy